Resonance announces Deal to distribute Diabetic Retinopathy AI tool
- 04 May 2018
Resonance Health is pleased to announce today that it has signed an agency agreement to distribute an Artificial Intelligence (AI) Diabetic Retinopathy (DR) grading tool. The contract is for a 2 year period, renewable based on performance and written agreement.
Resonance Health appoints new Non-Executive Director
- 01 March 2018
Resonance Health advises that it has appointed Mr. Mitchell Wells as a Non-Executive Director of the Company.
Resonance Health announce new CEO
- 23 February 2018
The Company has today announced the appointment of Alison Laws to the position of Chief Executive Officer for the Company, effective 23 February 2018.
Resonance Health News - December 2017
- 22 December 2017
Resonance Health is delighted to provide you with our latest quarterly newsletter where you can find an update on all our latest acitvities.
To read the newsletter please click here
We would like to take this opportunity to wish everyone a happy holidays and a safe and healthy 2018!
Collaborative Partnership commences to develop new AI diagnostic tools
- 17 October 2017
Resonance Health is pleased to announce a collaboration with Perth Radiological Clinic (PRC) with the signing of a JV term sheet. This JV allows RH and PRC to assess the viability of the development and commercialisation of several diagnostic tools.
Resonance Health News - September 2017
- 02 October 2017
We are very pleased to provide an update of our most recent and upcoming activities. It has been a very productive quarter and we look forward to further progressing our exciting AI project.
To view the newsletter please click here...